A pragmatic implementation research study for In Our DNA SC: a protocol to identify multi-level factors that support the implementation of a population-wide genomic screening initiative in diverse populations

BACKGROUND: In 2021, the Medical University of South Carolina (MUSC) partnered with Helix, a population genetic testing company, to offer population-wide genomic screening for Centers for Disease Control and Preventions’ Tier 1 conditions of hereditary breast and ovarian cancer, Lynch syndrome, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Allen, Caitlin G., Judge, Daniel P., Levin, Elissa, Sterba, Katherine, Hunt, Kelly, Ramos, Paula S., Melvin, Cathy, Wager, Karen, Catchpole, Kenneth, Clinton, Catherine, Ford, Marvella, McMahon, Lori L., Lenert, Leslie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052691/
https://www.ncbi.nlm.nih.gov/pubmed/35484601
http://dx.doi.org/10.1186/s43058-022-00286-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052691/
https://www.ncbi.nlm.nih.gov/pubmed/35484601
http://dx.doi.org/10.1186/s43058-022-00286-2

Ejemplares similares